Massachusetts Repeal Campaign Cites Teen Use Data; Experts Dispute Claims
Organizers pushing Question 4 cite youth consumption figures as legalization harms, but researchers question the methodology and causal link.

Two teenagers sit casually on a bench with a skateboard, embodying youthful skate culture.
Campaign Claims and Ballot Question 4
The Coalition for Safe Communities, the committee backing Question 4 on the November 2026 ballot, released a briefing September 17 asserting that teen cannabis use in Massachusetts has increased 18 percent since retail sales began in 2018. The measure would repeal Chapter 334 of the Acts of 2016, the ballot initiative that legalized possession, home cultivation, and commercial sale of cannabis for adults 21 and older. Campaign chair Dr. Kevin Sabet, president of Smart Approaches to Marijuana, told reporters the youth-use figure came from the Massachusetts Department of Public Health's Youth Risk Behavior Survey. He called it a clear policy failure.
Question 4 requires a simple majority to pass. Approval would shutter the state's 286 licensed retailers and cultivation facilities by January 1, 2027, and reinstate criminal penalties for possession of more than one ounce. The Cannabis Control Commission reported $1.9 billion in adult-use sales in fiscal 2026, generating $394 million in excise and sales tax revenue.
Researchers Challenge Methodology and Causation
Dr. Sharon Levy, director of the Adolescent Substance Use and Addiction Program at Boston Children's Hospital, said the 18 percent figure conflates two non-comparable survey cohorts and doesn't account for pandemic-era disruptions in school-based data collection. The Youth Risk Behavior Survey shifted from in-person to hybrid administration in 2021. The CDC has flagged that change as introducing potential response bias. Massachusetts teen cannabis use rates remain below the national median, Levy noted, and haven't diverged significantly from trends in states without legal adult markets.
Dr. Randi Melissa Schuster, director of neuropsychology at the Center for Addiction Medicine at Massachusetts General Hospital, told the Globe that state-level youth consumption data show no statistically significant uptick when adjusted for pre-legalization baseline trends. Schuster pointed to peer-reviewed studies in JAMA Pediatrics and the Journal of Adolescent Health. Both found no association between state legalization and increased youth prevalence.
Federal Survey Data and State Comparisons
National Survey on Drug Use and Health data for 2022–2025 show Massachusetts ranking 28th among states for past-30-day cannabis use among 12- to 17-year-olds, at 6.4 percent, compared to a national average of 6.8 percent. Colorado, which launched retail sales in 2014, reported a teen use rate of 7.1 percent in the same period. States without legal markets such as Texas and Georgia reported rates of 6.2 percent and 5.9 percent, respectively. The overlapping confidence intervals suggest no clear policy signal, according to researchers at the RAND Corporation's Drug Policy Research Center.
Teen access to cannabis has historically been driven by illicit supply chains, not licensed retail, noted Dr. Rosalie Liccardo Pacula, a RAND senior economist. Licensed stores require ID verification and face compliance audits. Massachusetts Cannabis Control Commission enforcement data for 2025 recorded 14 violations for sales to minors out of 47,000 compliance checks—a rate of 0.03 percent.
Campaign Funding and Opposition Coalition
The Coalition for Safe Communities has raised $4.2 million as of the September 10 campaign finance filing deadline, with $3.1 million contributed by SAM Action, the advocacy arm of Smart Approaches to Marijuana. Additional donors include the Massachusetts Medical Society ($250,000), the Massachusetts Chiefs of Police Association ($180,000), and the archdiocese of Boston ($150,000). The campaign hasn't disclosed individual donor names for contributions under $200.
Opposing Question 4 is the Committee to Protect Massachusetts Cannabis Laws, which has raised $8.7 million, primarily from multi-state operators including Curaleaf ($2.4 million), Trulieve ($1.9 million), and Verano ($1.1 million). Repeal would restore criminal penalties for possession, eliminate regulated testing and labeling, and redirect consumer demand to unregulated markets, the committee argues. Spokesperson Jim Borghesani called the campaign's youth-use claims "a recycled scare tactic unsupported by credible epidemiology."
Polling and Voter Outlook
A Suffolk University/Boston Globe poll conducted September 5–9 found 58 percent of likely voters oppose Question 4, with 34 percent in favor and 8 percent undecided. Support for repeal was highest among voters 65 and older (47 percent) and lowest among voters 18 to 34 (19 percent). The poll of 800 likely voters has a margin of error of ±3.5 percentage points. A separate UMass Amherst poll released September 12 showed similar results: 56 percent opposing repeal.
For full background on this story, see the CannIntel topic hub on the Massachusetts legalization repeal campaign. Early voting begins October 21. If Question 4 fails, Massachusetts will remain one of 24 states with legal adult-use markets. If it passes? It'd be the first voter-approved repeal of cannabis legalization in U.S. history.
For complete background, history, and our ongoing coverage of this story:
Open the CannIntel topic hub →Frequently asked questions
What does Massachusetts Question 4 do?
Question 4 would repeal the 2016 ballot initiative that legalized adult-use cannabis, shuttering 286 licensed facilities by January 1, 2027, and reinstating criminal penalties for possession over one ounce. It requires a simple majority to pass.
Has teen cannabis use increased in Massachusetts since legalization?
The repeal campaign claims an 18% increase, but researchers say the figure conflates non-comparable survey cohorts and ignores pandemic disruptions. National data show Massachusetts teen use at 6.4%, below the national average and unchanged from pre-legalization trends when adjusted for baseline.
Who is funding the repeal campaign?
The Coalition for Safe Communities has raised $4.2 million, with $3.1 million from Smart Approaches to Marijuana. Donors include the Massachusetts Medical Society, police chiefs, and the Boston archdiocese. Opposition has raised $8.7 million, mostly from MSOs like Curaleaf and Trulieve.
What do current polls show about Question 4?
A Suffolk University/Boston Globe poll from September 5–9 found 58% of likely voters oppose repeal, 34% support it, and 8% are undecided. Support is highest among voters 65+ and lowest among 18- to 34-year-olds.
What happens if Question 4 passes?
Massachusetts would become the first state to repeal voter-approved cannabis legalization. All retail and cultivation licenses would terminate January 1, 2027, and possession over one ounce would again be a criminal offense. The state would forfeit an estimated $400 million in annual tax revenue.
Sources
The cannabis newsletter you forward to your team.
Federal policy, market data, grower alerts, and the one story that matters today. Sent every weekday at 7am. Free.
No spam. Unsubscribe with one click. 21+ only.
Related from Laws

California DCC Says DEA Won't Answer Rescheduling Questions
State regulator reports federal agency remains silent on key implementation details months after Schedule III move.

Iowa AG Sand Declines to Back Recreational Cannabis at Town Hall
Brenna Bird's successor sidesteps legalization question, citing federal Schedule I status and legislative authority.

Federal Hemp THC Ban Extension Gives Operators Chemistry Problem
The extended compliance window shifts the burden from legal to technical, forcing hemp manufacturers to reformulate or exit.
More from the newsroom

Latinas in Cannabis Summit Returns to L.A. Sept. 26
Fourth annual gathering convenes entrepreneurs, cultivators, and executives for a day of networking and cultural celebration.

Missouri Recalls Pre-Rolled Joints After Mold Found in Testing
State regulators ordered the removal of contaminated cannabis products from dispensary shelves following failed microbial safety tests.

Trulieve Doubles Florida Investment as Federal Legalization Stalls
The MSO is accelerating state-level expansion while federal reform remains gridlocked in Congress.